Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 498

1.

[The influence of antipsychotic therapy on the cognitive functions of schizophrenic patients].

Tybura P, Mak M, Samochowiec A, Pełka-Wysiecka J, Grzywacz A, Grochans E, Zaremba-Pechmann L, Samochowiec J.

Psychiatr Pol. 2013 Jul-Aug;47(4):567-78. Polish.

PMID:
24946464
[PubMed - in process]
2.

Factors affecting cognitive remediation response in schizophrenia: the role of COMT gene and antipsychotic treatment.

Bosia M, Zanoletti A, Spangaro M, Buonocore M, Bechi M, Cocchi F, Pirovano A, Lorenzi C, Bramanti P, Smeraldi E, Cavallaro R.

Psychiatry Res. 2014 Jun 30;217(1-2):9-14. doi: 10.1016/j.psychres.2014.02.015. Epub 2014 Feb 19.

PMID:
24656901
[PubMed - in process]
3.

Association between serum testosterone levels, body mass index (BMI) and insulin in male patients with schizophrenia treated with atypical antipsychotics--olanzapine or risperidone.

Konarzewska B, Galińska-Skok B, Waszkiewicz N, Łazarczyk-Kirejczyk J, Malus A, Simonienko K, Szulc A.

Neuro Endocrinol Lett. 2014;35(1):50-7.

PMID:
24625910
[PubMed - indexed for MEDLINE]
4.

The effects of ketamine and risperidone on eye movement control in healthy volunteers.

Schmechtig A, Lees J, Perkins A, Altavilla A, Craig KJ, Dawson GR, William Deakin JF, Dourish CT, Evans LH, Koychev I, Weaver K, Smallman R, Walters J, Wilkinson LS, Morris R, Williams SC, Ettinger U.

Transl Psychiatry. 2013 Dec 10;3:e334. doi: 10.1038/tp.2013.109.

PMID:
24326395
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Current and future treatment modalities in schizophrenia: novel antipsychotic drugs and cognitive therapy.

J McKenna P, Mortimer AM.

Expert Rev Neurother. 2014 Jan;14(1):67-73. doi: 10.1586/14737175.2014.864237. Epub 2013 Dec 2.

PMID:
24308281
[PubMed - in process]
6.

Asenapine, blonanserin, iloperidone, lurasidone, and sertindole: distinctive clinical characteristics of 5 novel atypical antipsychotics.

Wang SM, Han C, Lee SJ, Patkar AA, Masand PS, Pae CU.

Clin Neuropharmacol. 2013 Nov-Dec;36(6):223-38. doi: 10.1097/WNF.0b013e3182aa38c4. Review.

PMID:
24201235
[PubMed - indexed for MEDLINE]
7.

Atypical antipsychotics for psychosis in adolescents.

Kumar A, Datta SS, Wright SD, Furtado VA, Russell PS.

Cochrane Database Syst Rev. 2013 Oct 15;10:CD009582. doi: 10.1002/14651858.CD009582.pub2. Review.

PMID:
24129841
[PubMed - indexed for MEDLINE]
8.

Translating the N-methyl-D-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia.

Meltzer HY, Rajagopal L, Huang M, Oyamada Y, Kwon S, Horiguchi M.

Int J Neuropsychopharmacol. 2013 Nov;16(10):2181-94. doi: 10.1017/S1461145713000928. Review.

PMID:
24099265
[PubMed - indexed for MEDLINE]
9.

[Adult onset Niemann-Pick type C disease and psychosis: literature review].

Maubert A, Hanon C, Metton JP.

Encephale. 2013 Oct;39(5):315-9. doi: 10.1016/j.encep.2013.04.013. Epub 2013 Aug 5. Review. French.

PMID:
23928063
[PubMed - indexed for MEDLINE]
10.

Effects of eight weeks of atypical antipsychotic treatment on middle frontal thickness in drug-naïve first-episode psychosis patients.

Goghari VM, Smith GN, Honer WG, Kopala LC, Thornton AE, Su W, Macewan GW, Lang DJ.

Schizophr Res. 2013 Sep;149(1-3):149-55. doi: 10.1016/j.schres.2013.06.025. Epub 2013 Jul 4.

PMID:
23830856
[PubMed - indexed for MEDLINE]
11.

Effects of risperidone and olanzapine dose reduction on cognitive function in stable patients with schizophrenia: an open-label, randomized, controlled, pilot study.

Takeuchi H, Suzuki T, Remington G, Bies RR, Abe T, Graff-Guerrero A, Watanabe K, Mimura M, Uchida H.

Schizophr Bull. 2013 Sep;39(5):993-8. doi: 10.1093/schbul/sbt090. Epub 2013 Jul 1.

PMID:
23821768
[PubMed - indexed for MEDLINE]
12.

Quetiapine and flupentixol differentially improve anterior cingulate cortex function in schizophrenia patients: an event-related potential study.

Schneider S, Bahmer TJ, Metzger FG, Reif A, Polak T, Pfuhlmann B, Walter G, Eberle MC, Ernst LH, Fallgatter AJ, Ehlis AC.

Int J Neuropsychopharmacol. 2013 Oct;16(9):1911-25. doi: 10.1017/S1461145713000540. Epub 2013 Jun 12.

PMID:
23759203
[PubMed - indexed for MEDLINE]
13.

Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research.

Celada P, Bortolozzi A, Artigas F.

CNS Drugs. 2013 Sep;27(9):703-16. doi: 10.1007/s40263-013-0071-0. Review.

PMID:
23757185
[PubMed - indexed for MEDLINE]
14.

[Early intervention practice in Toyama Prefecture: efforts to improve the clinical service].

Sumiyoshi T, Nishiyama S, Higuchi Y, Takahashi T, Matsuoka T, Muranaka Y, Kurachi M, Mizukami Y, Kazukawa S, Suzuki M.

Seishin Shinkeigaku Zasshi. 2013;115(2):180-6. Japanese.

PMID:
23691808
[PubMed - indexed for MEDLINE]
15.

Pharmacological approaches to the management of schizophrenia: 10 years on.

Castle D, Keks N, Newton R, Schweitzer I, Copolov D, Paoletti N, Burrows G, Tiller J.

Australas Psychiatry. 2013 Aug;21(4):329-34. doi: 10.1177/1039856213486211. Epub 2013 Apr 24. Review.

PMID:
23616381
[PubMed - indexed for MEDLINE]
16.

Influence of aripiprazole and olanzapine on behavioral dysfunctions of adolescent rats exposed to stress in perinatal period.

Ratajczak P, Kus K, Jarmuszkiewicz Z, Woźniak A, Cichocki M, Nowakowska E.

Pharmacol Rep. 2013;65(1):30-43.

PMID:
23563021
[PubMed - indexed for MEDLINE]
Free Article
17.

Effects of prenatal exposure to atypical antipsychotics on postnatal development and growth of infants: a case-controlled, prospective study.

Peng M, Gao K, Ding Y, Ou J, Calabrese JR, Wu R, Zhao J.

Psychopharmacology (Berl). 2013 Aug;228(4):577-84. doi: 10.1007/s00213-013-3060-6. Epub 2013 Apr 5.

PMID:
23559219
[PubMed - indexed for MEDLINE]
18.

Treating older adults with schizophrenia: challenges and opportunities.

Jeste DV, Maglione JE.

Schizophr Bull. 2013 Sep;39(5):966-8. doi: 10.1093/schbul/sbt043. Epub 2013 Apr 3.

PMID:
23552180
[PubMed - indexed for MEDLINE]
19.

Management of schizophrenia: clinical experience with asenapine.

Cortese L, Bressan RA, Castle DJ, Mosolov SN.

J Psychopharmacol. 2013 Apr;27(4 Suppl):14-22. doi: 10.1177/1359786813482533. Epub 2013 Mar 27. Review.

PMID:
23535351
[PubMed - indexed for MEDLINE]
20.

A randomized controlled trial of olanzapine improving memory deficits in Han Chinese patients with first-episode schizophrenia.

Wang CH, Li Y, Yang J, Su LY, Geng YG, Li H, Wang JK, Mu JL.

Schizophr Res. 2013 Mar;144(1-3):129-35. doi: 10.1016/j.schres.2012.12.021. Epub 2013 Jan 24.

PMID:
23352776
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk